Neoadjuvant vascular-targeted photodynamic therapy improves survival and reduces recurrence and progression in a mouse model of urothelial cancer
Abstract Locally advanced urothelial cancer has high recurrence and progression rates following surgical treatment. This highlights the need to develop neoadjuvant strategies that are both effective and well-tolerated. We hypothesized that neoadjuvant sub-ablative vascular-targeted photodynamic ther...
Guardado en:
Autores principales: | Barak Rosenzweig, Renato B. Corradi, Sadna Budhu, Ricardo Alvim, Pedro Recabal, Stephen La Rosa, Alex Somma, Sebastien Monette, Avigdor Scherz, Kwanghee Kim, Jonathan A. Coleman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b99c9791d8e04bdbafa07362f7919c94 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Photodynamic diagnosis in upper urinary tract urothelial carcinoma: A systematic review
por: Elsawi Osman, et al.
Publicado: (2017) -
Bladder Recurrence Following the Treatment of Upper Tract Urothelial Carcinoma
por: Takarn Itsaranujareankul, et al.
Publicado: (2021) -
Photodynamic therapy at the treatment of recurrent basal cell skin cancer
por: A. V. Belonogov, et al.
Publicado: (2014) -
Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder
por: Yu Li, et al.
Publicado: (2021) -
Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma
por: Masato Yanagi, et al.
Publicado: (2021)